EMG
ENZ

ETF Managers Group’s Enzo Biochem, Inc. ENZ Stock Holding History

ETF Managers Group’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,703
Closed -$43K – 853
2022
Q1 		$43K Buy
14,703
+52
+0.4% +$167 ﹤0.01% 664
2021
Q4 		$47K Sell
14,651
-2,625
-15% -$8.96K ﹤0.01% 669
2021
Q3 		$61K Buy
17,276
+3,051
+21% +$10.2K ﹤0.01% 651
2021
Q2 		$44K Sell
14,225
-446
-3% -$1.4K ﹤0.01% 639
2021
Q1 		$48K Sell
14,671
-8,625
-37% -$26.8K ﹤0.01% 652
2020
Q4 		$61K Sell
23,296
-3,543
-13% -$7.72K ﹤0.01% 608
2020
Q3 		$56K Buy
26,839
+13,654
+104% +$32.4K ﹤0.01% 611
2020
Q2 		$30K Buy
+13,185
New +$33.9K ﹤0.01% 595

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ETF Managers Group's ENZ Position: Q2 2022 in Review

ETF Managers Group sold out of Enzo Biochem, Inc. (ENZ) in Q2 2022, closing a stake of 14,703 shares — an estimated $43K sold.

ETF Managers Group first reported a position in ENZ in Q2 2020 and held it in 8 quarters. The position peaked at $61K in Q3 2021. 54 funds tracked by Wall St. Rank hold ENZ as of Q2 2022.

  • ETF Managers Group reported no remaining Enzo Biochem, Inc. position as of Q2 2022 after selling out during the quarter.
  • ETF Managers Group sold 14,703 Enzo Biochem, Inc. shares in Q2 2022, an estimated $43K.
  • ETF Managers Group first reported a position in Enzo Biochem, Inc. in Q2 2020 and held it in 8 quarters.
  • ETF Managers Group's Enzo Biochem, Inc. position peaked at $61K in Q3 2021.
  • 54 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2022.

Based on ETF Managers Group's 13F filing for Q2 2022, filed 15 Aug 2022.